Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Joel, Wight"'
Autor:
Maciej Tatarczuch, Katharine Louise Lewis, Ashray Gunjur, Briony Shaw, Li Mei Poon, Erin Paul, Matthew Ku, Mark Wong, Sylvia Ai, Ashley Beekman, Pietro R. Di Ciaccio, Michael Krigstein, Joel Wight, Caitlin Coombes, Michael Gilbertson, Amanda Tey, Jake Shortt, Chandramouli Nagarajan, Dipti Talaulikar, Nada Hamad, Sumita Ratnasingam, Shir‐Jing Ho, Tara Cochrane, Eliza A. Hawkes, Chan Y. Cheah, Stephen Opat, Gareth P. Gregory
Publikováno v:
eJHaem, Vol 5, Iss 4, Pp 709-720 (2024)
Abstract Background Despite recent advances, optimal therapeutic approaches applicable to subpopulations with primary central nervous system (CNS) lymphoma outside of clinical trials remain to be determined. Methods We performed a retrospective study
Externí odkaz:
https://doaj.org/article/a25d2050b12d409d88ac6bcc23b32d07
Autor:
Piers Blombery, Lucy Fox, Georgina L. Ryland, Ella R. Thompson, Jennifer Lickiss, Michelle McBean, Satwica Yerneni, Alison Trainer, David Hughes, Anthea Greenway, Francoise Mechinaud, Erica M. Wood, Graham J. Lieschke, Jeff Szer, Pasquale Barbaro, John Roy, Joel Wight, Elly Lynch, Melissa Martyn, Clara Gaff, David Ritchie
Publikováno v:
Haematologica, Vol 109, Iss 4 (2024)
Externí odkaz:
https://doaj.org/article/99877c55405a4964a40191b0e85eec8d
Autor:
Joel Wight, Piers Blombery, Jennifer Lickiss, Melinda Burgess, Clare Gould, Adrian Minson, Fiona Swain, Muhammed B. Sabdia, Maher K. Gandhi, Andrew Birchley, Colm Keane, Eliza A Hawkes
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/4684ac62e9984272b244f0770acb79ad
Autor:
Allison Barraclough, James T. England, Diego Villa, Joel Wight, Greg Hapgood, Jason Conn, Nicole Wong Doo, Eric Wenlong Li, Michael Gilbertson, Briony Shaw, Mark J. Bishton, Malik Saeed, Sumita Ratnasingam, Chathuri Abeyakoon, Geoff Chong, Shin Hnin Wai, Matthew Ku, Hui-Peng Lee, Kathryn Fleming, Constantine Tam, Genevieve Douglas, Chan Y. Cheah, Zi Yun Ng, Tukten Rolfe, Anthony K Mills, Nada Hamad, Helen Cashman, Mary Gleeson, Manjunath Narayana, Eliza A. Hawkes
Publikováno v:
Haematologica, Vol 108, Iss 9 (2023)
Grade (G) 3B follicular lymphoma (FL) is a rare FL subtype which exists on a histological continuum between ‘lowgrade’ (Grade 1, 2 and 3A FL) and diffuse large B-cell lymphoma (DLBCL) appearing to share features with each. Clinical characteristic
Externí odkaz:
https://doaj.org/article/83759b9a613345a6a23639746fdd8d71
Autor:
Kate Manos, Geoffrey Chong, Colm Keane, Sze-Ting Lee, Charmaine Smith, Leonid Churilov, Joseph McKendrick, William Renwick, Piers Blombery, Melinda Burgess, Niles Elizabeth Nelson, Tineke Fancourt, Joanne Hawking, Wendi Lin, Andrew M. Scott, Allison Barraclough, Joel Wight, Andrew Grigg, Chun Yew Fong, Eliza A. Hawkes
Publikováno v:
Leukemia. 37:1092-1102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f5fa424bbaa5539fb2036c364c19ae70
https://doi.org/10.1038/s41375-023-01863-7
https://doi.org/10.1038/s41375-023-01863-7
Autor:
Piers Blombery, Lucy Fox, Georgina L. Ryland, Ella R. Thompson, Jennifer Lickiss, Michelle McBean, Satwica Yerneni, David Hughes, Anthea Greenway, Francoise Mechinaud, Erica M. Wood, Graham J. Lieschke, Jeff Szer, Pasquale Barbaro, John Roy, Joel Wight, Elly Lynch, Melissa Martyn, Clara Gaff, David Ritchie
Publikováno v:
Haematologica, Vol 106, Iss 1 (2020)
Bone marrow failure (BMF) related to hypoplasia of hematopoietic elements in the bone marrow is a heterogeneous clinical entity with a broad differential diagnosis including both inherited and acquired causes. Accurate diagnostic categorization is cr
Externí odkaz:
https://doaj.org/article/bf72e299837c4352bbe6ebdc70e489e0
Autor:
Diva Baggio, Cameron Wellard, Eliza Chung, Dipti Talaulikar, Colm Keane, Stephen Opat, Pratyush Giri, Adrian Minson, Chan Yoon Cheah, Tasman Armytage, Denise Lee, Geoffrey Chong, Anna Johnston, Tara Cochrane, Neil Waters, Nada Hamad, Erica M. Wood, Eliza A. Hawkes, John Balendra, Allison Barraclough, Leanne Berkahn, Annmarie Bosco, Duncan Carradice, Hun Chuah, Luke Coyle, Kyle Crassini, Melita Kenealy, Matthew Ku, Teresa Leung, Kate Manos, Susan Morgan, Howard Mutsando, Manjunath Narayana, Emma Palfreymen, Miles Prince, Sumita Ratnasingam, Jock Simpson, Judith Trotman, Nicholas Viiala, Joel Wight
Publikováno v:
Leukemia & Lymphoma. 64:621-627
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::29304dce229d84e37522e36e35e90755
https://doi.org/10.1080/10428194.2022.2157676
https://doi.org/10.1080/10428194.2022.2157676
Autor:
Tasman Armytage, H Rose, Matthew Ku, Hui Peng Lee, Richard Khor, Belinda A. Campbell, Kenneth Lee, Michael Dickinson, Joel Wight, Sze Ting Lee, Maya Latimer, E Verner, Nada Hamad
Publikováno v:
Internal Medicine Journal. 52:1609-1623
Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoma subtype, accounting for 30-40% of lymphoma diagnoses. Though aggressive, cure is achievable in approximately 60% of cases with primary chemo-immunotherapy, and in a further substantial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38c6a9d5d7287ac62f1be67fa936b1ce
https://doi.org/10.1111/imj.15533
https://doi.org/10.1111/imj.15533
Autor:
Lynette C.Y. Chee, David M Ross, Shuh Ying Tan, Joel Wight, George Kannourakis, Miranda Ross, Wei Feng, Ying Jiang, Harveen Dhillon Natarajan, Christine Graham, Christopher Rovaldi, Simon Cooper, Jen L. Salstrom
Publikováno v:
Blood. 140:8181-8183
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72aee351e6970a163d029792539b17eb
https://doi.org/10.1182/blood-2022-166578
https://doi.org/10.1182/blood-2022-166578
Autor:
Anthony P. Schwarer, Jason Butler, Kathryn Jackson, Ashanka Beligaswatte, Louisa Martin, Glen Kennedy, Zantomio Daniela, Ian Lewis, Devendra Hiwase, Joel Wight, Simon He, Andrew Grigg, Kirk Morris, Peter Mollee, Paula Marlton
Publikováno v:
HemaSphere, Vol 2, Iss 6 (2018)
Abstract. The proportion of patients with acute myeloid leukemia (AML) cured is increased by administering high-dose cytarabine (HiDAC). It remains uncertain whether to administer HiDAC as induction or consolidation, and whether ≥1 cycle of HiDAC i
Externí odkaz:
https://doaj.org/article/a833d18f98a24370b143cc52f3a42cf3